Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Sep 15;387(11):1011-1020.
doi: 10.1056/NEJMra2206573. Epub 2022 Aug 31.

Covid-19 Vaccines - Immunity, Variants, Boosters

Dan H Barouch  1
Affiliations
Review

Covid-19 Vaccines - Immunity, Variants, Boosters

Dan H Barouch. N Engl J Med. .
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1. Immune Responses for Protection against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
Humoral and cellular immune responses contribute to protection against SARS-CoV-2 infection and coronavirus disease 2019 (Covid-19). Plus signs denote the relative importance of antibodies and T cells for protection in each category of disease severity, with more plus signs indicating greater importance.
Figure 2
Figure 2. Global Covid-19 Vaccination Rates.
Shown is the percentage of fully vaccinated persons by country as of July 8, 2022. Data are from the New York Times (www.nytimes.com/interactive/2021/world/covid-vaccinations-tracker.html).
Figure 3
Figure 3. SARS-CoV-2 Variants over Time.
Panel A shows global and weekly average case counts and frequencies of SARS-CoV-2 variants over time, and Panel B shows regional frequencies. The data are based on Pango lineage designations of sequences shared through the global collection of SARS-CoV-2 sequences and made available through the GISAID database from March 1, 2020, to July 8, 2022 (www.gisaid.org). Data are from Bette Korber and James Theiler at Los Alamos National Laboratories (https://cov.lanl.gov/content/index).
Figure 4
Figure 4. Protective Efficacy of Covid-19 Vaccines in the United States.
Covid-19 breakthrough rates (no. of cases per 100,000 vaccinated persons) are shown from April 4, 2021, to May 21, 2022, for persons who received the BNT162b2, mRNA-1273, or Ad26.COV2.S vaccines in the United States. Data are from the Centers for Disease Control and Prevention (https://covid.cdc.gov/covid-data-tracker/#rates-by-vaccine-status).
See this image and copyright information in PMC

References

    1. Gasteiger G, D’Osualdo A, Schubert DA, Weber A, Bruscia EM, Hartl D. Cellular innate immunity: an old game with new players. J Innate Immun 2017;9:111-125. - PMC - PubMed
    1. Bartsch YC, Tong X, Kang J, et al. Omicron variant Spike-specific antibody binding and Fc activity are preserved in recipients of mRNA or inactivated COVID-19 vaccines. Sci Transl Med 2022;14(642):eabn9243-eabn9243. - PMC - PubMed
    1. Chung AW, Kumar MP, Arnold KB, et al. Dissecting polyclonal vaccine-induced humoral immunity against HIV using systems serology. Cell 2015;163:988-998. - PMC - PubMed
    1. Sette A, Crotty S. Adaptive immunity to SARS-CoV-2 and COVID-19. Cell 2021;184:861-880. - PMC - PubMed
    1. Rydyznski Moderbacher C, Ramirez SI, Dan JM, et al. Antigen-specific adaptive immunity to SARS-CoV-2 in acute COVID-19 and associations with age and disease severity. Cell 2020;183(4):996-1012.e19. - PMC - PubMed

Substances

Supplementary concepts